Stockreport

Atea Pharmaceuticals GAAP EPS of -$0.53 misses by $0.09 [Seeking Alpha]

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF Cash, Cash Equivalents and Marketable Securities: $329.3 million on September 30, 2025, compared to $454.7 million at December 31, 2024. More on Atea Pharmaceuticals [Read more]